Atractylenolide-I Sensitizes Human Ovarian Cancer Cells to Paclitaxel by Blocking Activation of TLR4/MyD88-dependent Pathway
2014 · Scientific Reports · 78 citations
https://doi.org/10.1038/srep03840
X
Xiao Zha
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
523
Citations
10
h-index
11
i10-index
Xiao Zha is an academic researcher from Zunyi Medical University. The author has contributed to research in topics: Immunotherapy and Immune Responses & RNA Interference and Gene Delivery & Immune Response and Inflammation. The author has an h-index of 10, co-authored 18 publications.
Papers by this author
worksAtractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro
2016 · Journal of Translational Medicine · 45 citations
https://doi.org/10.1186/s12967-016-0845-5
ErbB3 Ligand Heregulin1 Is a Major Mitogenic Factor for Uncontrolled Lung Cancer Cell Proliferation
2019 · Neoplasia · 7 citations
https://doi.org/10.1016/j.neo.2019.02.001
[Expression of tyrosine kinase Syk in breast cancer and their clinical significance].
2004 · PubMed · 2 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat